When Did Tirzepatide Come Out? An In-Depth Look at Its Journey and Impact

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide’s story begins long before its public debut. The medication was developed by Eli Lilly and Company and stems from ongoing research into incretin-based therapies, which utilize hormones that regulate insulin and glucagon secretion. The concept of dual agonism—acting on both GIP and GLP-1

The Mechanism of Action

Understanding how tirzepatide works is crucial to appreciating its effectiveness. As a dual agonist, tirzepatide interacts with both GIP and GLP-1 receptors, leading to a series of physiological responses that aid in weight management and blood sugar control.

1. Gastric Inhibitory Polypeptide (GIP): GIP is a hormone released from the gut in response to food intake. It primarily stimulates insulin secretion from the pancreas, thereby lowering blood sugar levels. By enhancing insulin secretion, tirzepatide helps to regulate blood glucose effectively.

2. GLP-1 Receptor Agonism: GLP-1 is another hormone that plays a vital role in glucose metabolism. It not only stimulates insulin secretion but also suppresses glucagon release, slows gastric emptying, and promotes satiety. This makes GLP-1 agonists essential for weight loss, as they help reduce appetite and caloric intake.

Gastric Inhibitory Polypeptide (GIP) : GIP is a hormone released from the gut in response to food intake. It primarily stimulates insulin secretion from the pancreas, thereby lowering blood sugar levels. By enhancing insulin secretion, tirzepatide helps to regulate blood glucose effectively.

GLP-1 Receptor Agonism : GLP-1 is another hormone that plays a vital role in glucose metabolism. It not only stimulates insulin secretion but also suppresses glucagon release, slows gastric emptying, and promotes satiety. This makes GLP-1 agonists essential for weight loss, as they help reduce appetite and caloric intake.

By combining the actions of both GIP and GLP-1, tirzepatide offers a comprehensive strategy for managing diabetes and promoting weight loss.

The Impact of Tirzepatide on Weight Loss and Diabetes Management

The approval of tirzepatide has the potential to change the lives of millions struggling with obesity and type 2 diabetes. With obesity rates continuing to climb, innovative solutions like tirzepatide can offer renewed hope to individuals seeking effective treatment options.

Tirzepatide’s unique mechanism of action not only aids in weight loss but also addresses the underlying metabolic issues that often accompany obesity. This means that individuals who incorporate tirzepatide into their treatment plans may experience improvements in their overall health, including reduced risk factors for heart disease and other obesity-related conditions.

At PlexusDx, we understand that every weight loss journey is unique. PlexusDx's commitment to personalized care means that we guide individuals through their weight loss journeys with tailored solutions that fit their specific needs. By integrating medications like tirzepatide into the PlexusDx programs, we empower individuals to achieve their health goals in a safe and effective manner.

To see if you qualify for PlexusDx's prescription weight loss medications like tirzepatide, we encourage you to take PlexusDx's free assessment quiz here .

Additionally, for those who may not yet be ready for medication, PlexusDx offers quick-access supplements such as PlexusDx's GLP-1 Daily Support and Weight Loss Boost to support your weight loss efforts.

FAQ

When did tirzepatide first receive FDA approval?

What is the difference between Mounjaro and Zepbound?

How does tirzepatide help with weight loss?

Are there any side effects associated with tirzepatide?

How can I find out if I qualify for tirzepatide through PlexusDx?

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

When did tirzepatide first receive FDA approval?

Tirzepatide was first approved by the FDA in May 2022 under the brand name Mounjaro for the treatment of type 2 diabetes.

What is the difference between Mounjaro and Zepbound?

Mounjaro is the brand name for tirzepatide used for managing type 2 diabetes, while Zepbound is specifically approved for weight loss and the treatment of moderate to severe obstructive sleep apnea.

How does tirzepatide help with weight loss?

Tirzepatide acts on both GIP and GLP-1 receptors, which helps regulate blood sugar levels, decrease appetite, and promote feelings of fullness, ultimately leading to weight loss.

Are there any side effects associated with tirzepatide?

Common side effects include nausea, diarrhea, and vomiting. However, many individuals tolerate the medication well, and the benefits often outweigh the risks.

How can I find out if I qualify for tirzepatide through PlexusDx?

You can take PlexusDx's free assessment quiz to see if you qualify for prescription weight loss medications like tirzepatide by visitingthis link.

Related Reading

• Lifemd Tirzepatide
• Goodlife Meds Tirzepatide
• Noom Tirzepatide
• Orderly Meds Tirzepatide

Pricing and availability current as of May 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.